CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ... Discover historical prices for CBAY stock on Yahoo Finance. View daily, weekly or monthly format back to when CymaBay Therapeutics, Inc. stock was issued. Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing. Feb 7, 2024 · CymaBay Therapeutics (CBAY) SEC Filings & 10K Form. $24.00. -0.25 (-1.03%) (As of 02/7/2024 ET) Compare. Share. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability.Sep 12, 2023 · Find the latest news headlines from CymaBay Therapeutics Inc. Common Stock (CBAY) at Nasdaq.com.Dec 15, 2023 · Analysts have provided the following ratings for CymaBay Therapeutics (NASDAQ:CBAY) within the last quarter: In the last 3 months, 6 analysts have offered 12-month price targets for CymaBay ...Capital Small Share Price: Find the latest news on Capital Small Stock Price. Get all the information on Capital Small with historic price charts for NSE / BSE. Experts …Cymabay Therapeutics (CBAY) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Feb 9, 2024 · NASDAQ: CBAY · IEX Real-Time Price · USD. Add to Watchlist 24.95 +0.95 (3.96%) Feb 8, 2024, 3:03 PM EST - Market open. Overview; Financials; Statistics; Forecast; Dividends; Profile; Chart; Statistics; Market Cap; Revenue; CymaBay Therapeutics Revenue. CymaBay Therapeutics had revenue of $31.02M in the twelve …Is CymaBay Therapeutics Stock Undervalued? The current CymaBay Therapeutics [CBAY] share price is $32.21. The Score for CBAY is 100, which is 100% above its ...Feb 12, 2024 · CymaBay stock skyrocketed Monday after Gilead Sciences announced it will buy it for $4.3 billion. CBAY stock surged almost 25%. ... Realtime quote and/or trade prices are not sourced from all markets. 4 days ago · CBAY is trading at a 1% premium. Price $23.84 Feb 2, 2024 Fair Value $67.78 Feb 2, 2024 Uncertainty Very High 1-Star Price $25.73 Find the latest Centerra Gold Inc. (CGAU) stock quote, history, news and other vital information to help you with your stock trading and investing.CymaBay Therapeutics Inc. (CBAY) closed the last trading session at $16.44, gaining 15.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...CBAY has gained $0.28 from the previous closing price of $23.71 on volume of 535,102 shares. Over the past year the S&P 500 is higher by 23.21% while CBAY has gained 302.52%. CBAY lost -$0.93 per share the over the last 12 months. Click Here to get the full Stock Report for CymaBay Therapeutics Inc stock.View the latest CBAY earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. S&P 500 5,088.80. DOW 39,131.53. ...Mar 28, 2023 · Shares of CymaBay Therapeutics Inc. (CBAY) have gained 11.4% over the past four weeks to close the last trading session at $8.73, but there could still be a solid upside left in the stock if short ...Feb 13, 2024 · CymaBay Therapeutics (CBAY) CymaBay Therapeutics received a Hold rating and a $32.50 price target from H.C. Wainwright analyst Ed Arce today. The company’s shares closed last Monday at $32.21 ... Feb 16, 2024 · Ticker Symbol: CBAY: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001042074: CUSIP Number: 23257D103: ISIN Number: US23257D1037Feb 15, 2024 · (CBAY Quick Quote CBAY - Free Report) , for $32.50 per share in cash or a total equity value of $4.3 billion. Shares of CBAY surged on the acquisition news as the offer price represents 27% of the ... The exercise price per share for the stock options granted by CymaBay Therapeutics, Inc. is $32.18. How will the stock options vest for the employees at CymaBay ...CBAY has fallen -$0.10 from the previous closing price of $22.85 on volume of 483,390 shares. Over the past year the S&P 500 has gained 21.52% while CBAY has gained 191.67%. CBAY lost -$0.93 per share the over the last 12 months. Click Here to get the full Stock Report for CymaBay Therapeutics Inc stock.Get the latest stock price, news and history of CymaBay Therapeutics Inc. Common Stock (CBAY), a biotechnology company developing treatments for neurological disorders. See …CBAYNasdaq Stock Market • NLS real time price • CURRENCY IN USD • Biotechnology & Medical Research. CYMABAY THERAPEUTICS, INC. (CBAY). 32.18. at close. -0.02 ...Find the latest eBay Inc. (EBAY) stock quote, history, news and other vital information to help you with your stock trading and investing. A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. CBAY is quite a good fit in this regard, gaining 12.1% ...2 days ago · CBAY is the ticker symbol for CymaBay Therapeutics Inc., a biotech company that develops treatments for rare liver diseases. The stock price, news, analysis, and ratings are updated on a delayed basis. As of Jan 25, 2024 7:59 p.m. EST, the stock closed at $22.23, down 1.02% from the previous day. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Interactive stock price chart for CymaBay Therapeutics, Inc. (CBAY) with real-time updates, full price history, technical analysis and more.Based on 7 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $28.67 with a high forecast of $36.00 and a low forecast of $20.00. The average price target represents a 20.61% change from the last price of $23.77. Highest Price Target $36.00. Average Price Target $28.67.Daniel Menold, Vice President, Finance of CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 10,000 shares of the company on January 16, 2024, according to a recent SEC Filing. Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.The average one-year price target for CymaBay Therapeutics (NasdaqGS:CBAY) has been revised to 31.36 / share. This is an increase of 12.84% from the prior estimate of 27.80 dated January 16, 2024.The consensus price target hints at a 40.3% upside potential for CymaBay Therapeutics Inc. (CBAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. Feb 12, 2024 ... This has Gilead valuing shares of CBAY stock at $32.50 apiece. CBAY Stock - Why is CymaBay (CBAY) Stock Up 25% Today? Source: Sundry Photography ...Cymabay Therapeutics Inc stock is currently priced at $32.13, with a 24-hour trading volume of 24.78M. ... Cymabay Therapeutics Inc Stock (CBAY) Financials Data Cymabay Therapeutics Inc (CBAY) Net Income 2023. CBAY net income (TTM) was -$90.10 million for the quarter ending September 30, 2023, a +14.93% increase year-over-year.Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals Market Capitalization, $K 3,652,614 Shares Outstanding, K 113,400 …You can buy or sell CBAY and other ETFs, options, and stocks. View the real-time CBAY price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule at rbnhd ... Dec 5, 2022 ... ... cbay a good stock to buy, also is cbay a buy or sell? While analyzing cbay stock price target or doing the cbay stock review, it is ...4 days ago · A high-level overview of CymaBay Therapeutics, Inc. (CBAY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Cymabay Therapeutics Stock Forecast, CBAY stock price prediction. Price target in 14 days: 39.325 USD. The best long-term & short-term Cymabay Therapeutics ...What happened. Shares of CymaBay Therapeutics ( CBAY 2.92%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ...Read more about CBAY stock here. ... In addition, it also sold pre-funded warrants to purchase 2,142,857 shares of common stock in the offering, at a public price of $6.9999 per underlying share ...In depth view into CBAY (CymaBay Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. CymaBay Therapeutics Inc (CBAY) 23.80 -0.02 ( -0.06% ) USD | NASDAQ | Feb 05, 13:04Find out the direct holders, institutional holders and mutual fund holders for CymaBay Therapeutics, Inc. (CBAY). Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...Stock analysis for Cymabay Therapeutics Inc (CBAY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Dec 5, 2022 ... ... cbay a good stock to buy, also is cbay a buy or sell? While analyzing cbay stock price target or doing the cbay stock review, it is ...CBAYNasdaq Stock Market • NLS real time price • CURRENCY IN USD • Biotechnology & Medical Research. CYMABAY THERAPEUTICS, INC. (CBAY). 32.18. at close. -0.02 ...CBAY price to book (PB)For valuing companies that are loss-making or have lots of physical asset. Company. 11.17x. Industry. 5.88x. ... Cymabay Therapeutics 's market cap is calculated by multiplying CBAY's current stock price of $32.12 by CBAY's total outstanding shares of 113,403,353.Sep 9, 2023 · He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. ... *Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.Aug 14, 2023 · CymaBay Therapeutics stock price target raised to $16 from $8 at B. Riley MarketWatch. Wednesday, May 18, 2022. 07:27 AM ET. CymaBay Therapeutics stock price target cut to $8 from $10 at B. Riley MarketWatch. Wednesday, May 13, 2020. 07:47 AM ET. CymaBay Therapeutics stock price target raised to $6.00 from $1.50 at B. Riley FBR …Dec 28, 2023 ... CymaBay Therapeutics (CBAY) is sprinting to the finish line with a breakthrough treatment for a serious liver disease. And it's pushing CBAY ...CymaBay Therapeutics (CBAY) CymaBay Therapeutics received a Hold rating and a $32.50 price target from H.C. Wainwright analyst Ed Arce today. The …Feb 7, 2024 · CBAY News. 6 days ago - CymaBay Therapeutics to Participate in Upcoming Investment Conferences - GlobeNewsWire 20 days ago - CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire 4 weeks ago - New Published Data Demonstrates Correlation Between Itch Cytokine Interleukin-31 …B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on CymaBay Therapeutics (CBAY – Research Report) today and set a price ta...2 days ago · The Cymabay Therapeutics Inc stock price fell by -0.279% on the last day (Tuesday, 13th Feb 2024) from $32.21 to $32.12. During the last trading day the stock fluctuated 0.374% from a day low at $32.09 to a day high of $32.21. The price has risen in 6 of the last 10 days and is up by 35.81% over the past 2 weeks. 3 days ago · CBAY stock jumped 3.5% the day Genfit and Ipsen reported these results on Nov. 13. Genfit shares eked out a fractional gain. ... *Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade ...A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. CBAY is quite a good fit in this regard, gaining 12.1% ...In 2016, MSI acquired UK-based Airwave Systems. Find the latest Cal Bay International, Inc. (CBYI) stock quote, history, news and other vital information to help you with your stock trading and ...Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. ... Cymabay Therapeu stock (CBAY) in USD. 1 CBAY = 24 USD. 1 month. 6 months. 1 year. 5 years. Cymabay Therapeu stock performance at a glance. Check Cymabay Therapeu’s past …Interactive stock price chart for CymaBay Therapeutics, Inc. (CBAY) with real-time updates, full price history, technical analysis and more.Fiscal Q3 2023 ended 9/30/23. Reported on 11/6/23. Get the latest CymaBay Therapeutics Inc (CBAY) real-time quote, historical performance, charts, and other financial …The CymaBay Therapeutics 52-week low stock price is 7.26, which is 77.5% below the current share price. The average CymaBay Therapeutics stock price for the last 52 weeks is 14.09. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. CymaBay Therapeutics Inc. is a biopharmaceutical company. CymaBay Therapeutics Market Cap: 2.61B, Enterprise value: 762.95M, P/E: -7.31, PEG ratio: -1.54, EPS: -1.09, Revenue: N/A, EBITDA: -74.92M, Income: -106.15M ...5 days ago · CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that The New England Journal of Medicine (NEJM) has published detailed results from the RESPONSE Phase 3 trial evaluating seladelpar, an investigational …Nov 6, 2023 · Over the past 3 months, 14 analysts have published their opinion on CymaBay Therapeutics (NASDAQ:CBAY) stock. These analysts are typically employed by large Wall Street banks and tasked with ...Sep 9, 2023 · He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. ... *Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.CymaBay Therapeutics (CBAY) Options Chain & Prices. $25.69. +0.73 (+2.92%) (As of 02/9/2024 ET) Compare. Share. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability.Based on analysts projections #CBAY is expected to experience a price decline over the next year. The current average CBAY price target, as estimated by these analysts, is $0.00.. The predictions for the future CBAY stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for CBAY.. It is important to …Daniel Menold, Vice President, Finance of CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 10,000 shares of the company on January 16, 2024, according to a recent SEC …The CymaBay Therapeutics stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of CBAY stock is predicted to drop by -2.56% tomorrow and lose -2.59% in the next 7 days. This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price on Friday. Gilead Sciences is acquiring ...Get the latest CymaBay Therapeutics, Inc. (CBAY) stock news and headlines to help you in your trading and investing decisions.Find the latest Centerra Gold Inc. (CGAU) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.Dec 5, 2022 ... ... cbay a good stock to buy, also is cbay a buy or sell? While analyzing cbay stock price target or doing the cbay stock review, it is ...Daniel Menold, Vice President, Finance of CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 10,000 shares of the company on January 16, 2024, according to a recent SEC …Dec 15, 2023 · Analysts have provided the following ratings for CymaBay Therapeutics (NASDAQ:CBAY) within the last quarter: In the last 3 months, 6 analysts have offered 12-month price targets for CymaBay ...Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cymabay Therapeu stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock. apple; wise; Select a currency. USD. …This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price on Friday. Gilead Sciences is acquiring ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.View CymaBay Therapeutics, Inc. CBAY stock quote prices, financial information, real-time forecasts, and company news from CNN.Today, it's easy to get free stocks! In most cases, all you have to do is sign up for one of the investing apps on this list. Getting free stocks is simple - all you have to do is ...Mar 28, 2023 · Shares of CymaBay Therapeutics Inc. (CBAY) have gained 11.4% over the past four weeks to close the last trading session at $8.73, but there could still be a solid upside left in the stock if short ...
Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may.... Devel 16
5 days ago · Get CymaBay Therapeutics Inc (CBAY.PH) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsVinFast Auto Ltd. Ordinary Shares. $17.15 -0.84 -4.67%. CymaBay Therapeutics Inc. Common Stock (CBAY) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data ...View eBay Inc. EBAY stock quote prices, financial information, real-time forecasts, and company news from CNN.Ticker Symbol: CBAY: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001042074: CUSIP Number: 23257D103: ISIN Number: US23257D1037CBAY price to book (PB)For valuing companies that are loss-making or have lots of physical asset. Company. 11.17x. Industry. 5.88x. ... Cymabay Therapeutics 's market cap is calculated by multiplying CBAY's current stock price of $32.12 by CBAY's total outstanding shares of 113,403,353.Feb 7, 2024 · CBAY News. 6 days ago - CymaBay Therapeutics to Participate in Upcoming Investment Conferences - GlobeNewsWire 20 days ago - CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire 4 weeks ago - New Published Data Demonstrates Correlation Between Itch Cytokine Interleukin-31 …Interactive stock price chart for CymaBay Therapeutics, Inc. (CBAY) with real-time updates, full price history, technical analysis and more.CymaBay stock skyrocketed Monday after Gilead Sciences announced it will buy it for $4.3 billion. CBAY stock surged almost 25%. ... Realtime quote and/or trade prices are not sourced from all markets.Feb 12, 2024 ... This has Gilead valuing shares of CBAY stock at $32.50 apiece. CBAY Stock - Why is CymaBay (CBAY) Stock Up 25% Today? Source: Sundry Photography ...View CymaBay Therapeutics (NASDAQ:CBAY) historical prices, past price performance, and an advanced CBAY stock chart at MarketBeat.CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for investigational treatment, seladelpar, for the management of primary biliary ...Feb 12, 2024 · Feb 12 (Reuters) - Gilead Sciences (GILD.O), opens new tab has agreed to buy CymaBay Therapeutics (CBAY.O), opens new tab for $4.3 billion, gaining access to an experimental liver disease ...Real time CymaBay Therapeutics (CBAY) stock price quote, stock graph, news & analysis. Based on 7 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $28.67 with a high forecast of $36.00 and a low forecast of $20.00. The average price target represents a 20.61% change from the last price of $23.77. Highest Price Target $36.00. Average Price Target $28.67.Webull offers CBAY Ent Holdg (CBAY) historical stock prices, in-depth market analysis, NASDAQ: CBAY real-time stock quote data, in-depth charts, free CBAY options chain data, and a fully built financial calendar to help you invest smart. .
Popular Topics
- Aps parent portalVale store near me
- Down under men at workCheapest flights europe
- Sheff utd vs newcastleIce cream shop open near me
- Buy now pay later virtual cardAmor eterno with lyrics
- Mind playing tricks on meLangley near me
- Lg smart tv apps downloadMr snuffleupagus
- A house is not a homeCheap flights from atlanta to las vegas